Minami M, Togashi H, Matsumoto M, Yoshioka M, Hamaue N, Amemiya N, Saito H
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Higashi-Nippon Gakuen University, Japan.
Hokkaido Igaku Zasshi. 1988 Mar;63(2):232-9.
The present study was undertaken to elucidate the effects of ketanserin and trichlormethiazide on blood pressure in stroke-prone spontaneously hypertensive rats (SHRSP). Oral ketanserin and trichlormethiazide were administered to separate groups for 4 weeks. Combined ketanserin and trichlormethiazide was also administered and the effects observed. 1) In both ketanserin and trichlormethiazide administered groups, significant antihypertensive actions were observed as compared with the non-treated SHRSP. 2) In the ketanserin administered group, a significant increase in water drinking activity was observed, accompanied with an increased urinary volume. 3) In the trichlormethiazide administered group, urinary sodium excretion decreased significantly, accompanied with an increased urinary norepinephrine excretion. 4) Combined administration of ketanserin and trichlormethiazide enhanced the decreases in blood pressure which were produced by single administration of either ketanserin or trichlormethiazide. Moreover, both the increasing tendency in the urinary sodium excretion and the decreasing tendency in the urinary norepinephrine excretion occurred after the combined administration in SHRSP. These findings suggest that ketanserin produces an antihypertensive effect and may act prophylactically for thiazide-induced renal impairment in SHRSP.
本研究旨在阐明酮色林和三氯噻嗪对易卒中型自发性高血压大鼠(SHRSP)血压的影响。将口服酮色林和三氯噻嗪分别给予不同组,持续4周。同时给予酮色林和三氯噻嗪联合用药并观察其效果。1)在给予酮色林和三氯噻嗪的两组中,与未治疗的SHRSP相比,均观察到显著的降压作用。2)在给予酮色林的组中,观察到饮水活动显著增加,同时尿量增加。3)在给予三氯噻嗪的组中,尿钠排泄显著减少,同时尿去甲肾上腺素排泄增加。4)酮色林和三氯噻嗪联合给药增强了单独给予酮色林或三氯噻嗪所产生的血压下降。此外,在SHRSP联合给药后,尿钠排泄增加趋势和尿去甲肾上腺素排泄减少趋势均出现。这些发现表明,酮色林产生降压作用,并可能对SHRSP中噻嗪类药物诱导的肾损害起到预防性作用。